Two Sigma Investments, LP Aveo Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.48 - $14.97 $513,879 - $907,167	60,599 Added 128.93%	107,601 $1.61 Million
Q3 2022 Nov 14, 2022	BUY	$6.61 - $8.72 $310,683 - $409,857	47,002 New	47,002 $387,000
Q3 2021 Nov 15, 2021	SELL	$5.12 - $6.89 $1.08 Million - $1.46 Million	-211,723 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.21 - $7.45 $985,204 - $1.18 Million	158,648 Added 298.91%	211,723 $1.4 Million
Q1 2021 May 17, 2021	SELL	$5.97 - $15.28 $280,052 - $716,784	-46,910 Reduced 46.92%	53,075 $389,000
Q4 2020 Feb 16, 2021	BUY	$5.08 - $6.68 $507,923 - $667,899	99,985 New	99,985 $577,000
Q3 2020 Nov 16, 2020	SELL	$4.16 - $6.26 $641,089 - $964,716	-154,108 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.47 - $9.99 $488,128 - $1.41 Million	140,671 Added 1046.89%	154,108 $794,000
Q1 2020 May 15, 2020	BUY	$2.6 - $6.9 $34,936 - $92,715	13,437 New	13,437 $49,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.